RxDoctor Payments Data

Austin Chiang, MD

Gastroenterology · Philadelphia, PANPI 1104118843

Payments from drug & device makers

$27,672in general payments, 2019–2025

Across 66 payments — averaging $419.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$13K
  • Modernatx, Inc.$11K
  • Medtronic$2K
  • Olympus Corporation$773
  • Covidien LP$184
  • Steris Corporation$151
  • plus $287 from 3 others

What the payments were for

  • Consulting fees$20,08373%
  • Speaking & faculty fees$2,4959%
  • Travel & lodging$2,4549%
  • Food & beverage$2,64010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific52$13,196
Modernatx, Inc.2$11,115
Medtronic5$1,966
Olympus Corporation1$773
Covidien LP2$184
Steris Corporation1$151
Fujifilm Healthcare Americas Corporation1$138
Medrobotics Inc.1$124
Current Health, Inc.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,672 in reported general payments places this provider in the 80th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$10,976
Medicare patients
51
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide13$17,172
Topiramate11$747
Omeprazole21$170

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →